Pepdox
Studies
Peptides
Calculator
Corrigendum: Safety of Semaglutide. | Pepdox
Home
/
Search
/
PMID 34858353
Corrigendum: Safety of Semaglutide.
Frontiers in endocrinology
2021
PMID: 34858353
View on PubMed
DOI: 10.3389/fendo.2021.786732
Semaglutide
Abstract
[This corrects the article DOI: 10.3389/fendo.2021.645563.].
Authors
Smits, Mark M; Van Raalte, Daniël H
Keywords
glucagon-like peptide-1 receptor agonist (GLP-1RA)
oral
safety
semaglutide
subcutaneous
type 2 diabetes